Related Experiment Video
Updated: Jun 24, 2026

Measuring the Stiffness of Ex Vivo Mouse Aortas Using Atomic Force Microscopy
Published on: October 19, 2016
Is lowering phosphate exposure the key to preventing arterial stiffening with age?
C J Ferro1, C D Chue, R P Steeds
1Department of Nephrology, Queen Elizabeth Hospital, University Hospital Birmingham NHS Foundation Trust, Edgbaston, Birmingham, West Midlands B15 2TH, UK. charles.ferro@uhb.nhs.uk
Insights
High dietary phosphate intake accelerates arteriosclerosis and arterial stiffness, contributing to cardiovascular disease. Reducing phosphate consumption may significantly lower cardiovascular mortality and morbidity.
Area of Science:
- Cardiovascular science
- Nephrology
- Nutritional science
Background:
- Cardiovascular disease is the leading global cause of death.
- Arteriosclerosis, characterized by arterial stiffness, contributes significantly to cardiovascular mortality.
- Serum phosphate is an emerging cardiovascular risk factor implicated in arteriosclerosis and arterial calcification.
Purpose of the Study:
- To highlight the overlooked role of arteriosclerotic vascular disease in cardiovascular mortality.
- To explore the link between dietary phosphate, renal function, and arteriosclerosis.
- To propose phosphate reduction as a strategy to mitigate cardiovascular risk.
Main Methods:
- This is a viewpoint article, presenting a hypothesis based on existing literature.
- It reviews the determinants of serum phosphate, including diet and renal function.
- It discusses the impact of phosphate on arterial stiffness and cardiovascular health.
Main Results:
- Diets in affluent populations are high in phosphate due to animal protein and preservatives.
- Ageing populations often have reduced renal function, exacerbating phosphate retention.
- Phosphate-rich diets, combined with declining kidney function, accelerate arteriosclerosis.
Conclusions:
- Phosphate-rich diets, especially in individuals with diminished renal function, accelerate arteriosclerosis and arterial stiffness.
- Reducing dietary phosphate intake is hypothesized to attenuate arterial stiffness progression.
- This intervention may lead to substantial reductions in cardiovascular mortality and morbidity.
Abstract:
Cardiovascular disease remains the leading cause of death world wide. Although atheroma is clearly important, the role of arteriosclerotic vascular disease is often overlooked. Arteriosclerosis causes increased arterial stiffness, with consequent systolic hypertension and left ventricular hypertrophy. Serum phosphate is increasingly being recognised as a cardiovascular risk factor and has been implicated in the development of arteriosclerosis and arterial calcification. Its determinants are unclear, but both diet and minor reductions in renal function may be important. Diets in affluent populations are high in phosphate because of increased consumption of animal protein and the use of phosphate-containing preservatives. This viewpoint suggests that the consumption of a phosphate-rich diet, exacerbated by the high prevalence of chronic kidney disease found in ageing populations, accelerates the development of arteriosclerosis. It is hypothesised that reducing phosphate intake will attenuate the progression of arterial stiffness with major beneficial effects upon cardiovascular mortality and morbidity.
Related Concept Videos
Atherosclerosis III: Management
Peripheral Artery Disease III: Interprofessional Care
Peripheral Artery Disease I: Introduction
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
Pharmacodynamics in Geriatric Patients: Effects of Age
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...

